141 related articles for article (PubMed ID: 21154529)
1. Synthesis of peptidomimetic conjugates of cyclic nucleoside phosphonates.
Serpi M; Krylov IS; Zakharova VM; McKenna CE
Curr Protoc Nucleic Acid Chem; 2010 Dec; Chapter 15():Unit15.4. PubMed ID: 21154529
[TBL] [Abstract][Full Text] [Related]
2. Serine side chain-linked peptidomimetic conjugates of cyclic HPMPC and HPMPA: synthesis and interaction with hPEPT1.
Peterson LW; Sala-Rabanal M; Krylov IS; Serpi M; Kashemirov BA; McKenna CE
Mol Pharm; 2010 Dec; 7(6):2349-61. PubMed ID: 20929265
[TBL] [Abstract][Full Text] [Related]
3. Evolution of an amino acid based prodrug approach: stay tuned.
Krylov IS; Kashemirov BA; Hilfinger JM; McKenna CE
Mol Pharm; 2013 Feb; 10(2):445-58. PubMed ID: 23339402
[TBL] [Abstract][Full Text] [Related]
4. Serine peptide phosphoester prodrugs of cyclic cidofovir: synthesis, transport, and antiviral activity.
Eriksson U; Peterson LW; Kashemirov BA; Hilfinger JM; Drach JC; Borysko KZ; Breitenbach JM; Kim JS; Mitchell S; Kijek P; McKenna CE
Mol Pharm; 2008; 5(4):598-609. PubMed ID: 18481868
[TBL] [Abstract][Full Text] [Related]
5. Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art.
Hostetler KY
Antiviral Res; 2009 May; 82(2):A84-98. PubMed ID: 19425198
[TBL] [Abstract][Full Text] [Related]
6. N(4)-Acyl derivatives as lipophilic prodrugs of cidofovir and its 5-azacytosine analogue, (S)-HPMP-5-azaC: chemistry and antiviral activity.
Krečmerová M; Pohl R; Masojídková M; Balzarini J; Snoeck R; Andrei G
Bioorg Med Chem; 2014 May; 22(10):2896-906. PubMed ID: 24731540
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of acyclic nucleoside phosphonates.
Holý A
Curr Protoc Nucleic Acid Chem; 2005 Oct; Chapter 14():Unit 14.2. PubMed ID: 18428938
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the in vitro growth of Plasmodium falciparum by acyclic nucleoside phosphonates.
Smeijsters LJ; Franssen FF; Naesens L; de Vries E; Holý A; Balzarini J; de Clercq E; Overdulve JP
Int J Antimicrob Agents; 1999 Jun; 12(1):53-61. PubMed ID: 10389648
[TBL] [Abstract][Full Text] [Related]
9. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
Aduma P; Connelly MC; Srinivas RV; Fridland A
Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
[TBL] [Abstract][Full Text] [Related]
10. Symmetrical diamidate prodrugs of nucleotide analogues for drug delivery.
Pertusati F; McGuigan C; Serpi M
Curr Protoc Nucleic Acid Chem; 2015 Mar; 60():15.6.1-15.6.10. PubMed ID: 25754890
[TBL] [Abstract][Full Text] [Related]
11. Approaches to tyrosine-linked peptidomimetic prodrugs of (S)-HPMP-based acyclic nucleoside phosphonates.
Zakharova VM; Krylov IS; Serpi M; Kashemirov BA; McKenna CE
Phosphorus Sulfur Silicon Relat Elem; 2011; 186(4):968-969. PubMed ID: 21566698
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of cidofovir and (S)-HPMPA ether lipid prodrugs.
Beadle JR
Curr Protoc Nucleic Acid Chem; 2007 Jun; Chapter 15():Unit 15.2. PubMed ID: 18428972
[TBL] [Abstract][Full Text] [Related]
13. Ester prodrugs of acyclic nucleoside thiophosphonates compared to phosphonates: synthesis, antiviral activity and decomposition study.
Roux L; Priet S; Payrot N; Weck C; Fournier M; Zoulim F; Balzarini J; Canard B; Alvarez K
Eur J Med Chem; 2013 May; 63():869-81. PubMed ID: 23603046
[TBL] [Abstract][Full Text] [Related]
14. Some novel aminopropyl nucleoside phosphonates.
Zhou D; Lagoja IM; Van Aerschot A
Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):563-6. PubMed ID: 18066856
[TBL] [Abstract][Full Text] [Related]
15. [Design, synthesis and anti-HBV activity of L-amino acid ester prodrugs of acyclic nucleoside phosphonates].
Fu XZ; Jiang SH; Yang YS; Ji RY
Yao Xue Xue Bao; 2008 May; 43(5):495-503. PubMed ID: 18717337
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activation of an ethylene glycol-linked amino acid conjugate of cyclic cidofovir.
Eriksson U; Hilfinger JM; Kim JS; Mitchell S; Kijek P; Borysko KZ; Breitenbach JM; Drach JC; Kashemirov BA; McKenna CE
Bioorg Med Chem Lett; 2007 Feb; 17(3):583-6. PubMed ID: 17161946
[TBL] [Abstract][Full Text] [Related]
17. Phosphonates and Phosphonate Prodrugs in Medicinal Chemistry: Past Successes and Future Prospects.
Krečmerová M; Majer P; Rais R; Slusher BS
Front Chem; 2022; 10():889737. PubMed ID: 35668826
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in the synthesis of cyclic 5'-nornucleoside phosphonate analogues.
Shen GH; Hong JH
Carbohydr Res; 2018 Jun; 463():47-106. PubMed ID: 29772449
[TBL] [Abstract][Full Text] [Related]
19. Medicinal chemistry of fluorinated cyclic and acyclic nucleoside phosphonates.
Baszczyňski O; Janeba Z
Med Res Rev; 2013 Nov; 33(6):1304-44. PubMed ID: 23893552
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological properties of prodrugs of (S)-3-(adenin-9-yl)-2-(phosphonomethoxy)propanoic acid.
Kaiser MM; Poštová-Slavětínská L; Dračínský M; Lee YJ; Tian Y; Janeba Z
Eur J Med Chem; 2016 Jan; 108():374-380. PubMed ID: 26706348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
